Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mania and Antimanic Drugs: Overview

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...

Bipolar Disorder

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.

Electroconvulsive Therapy

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Psychosis and Antipsychotic Drugs: Overview

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Loss of function of Noggin inhibits glial scar formation and motor function recovery after spinal cord injury.

Frontiers in neural circuits·2026

Same author

Exploration of the shared pathways and common biomarker in adamantinomatous craniopharyngioma and type 2 diabetes using integrated bioinformatics analysis.

PloS one·2024

Same author

Molecular Mechanisms in the Vascular and Nervous Systems following Traumatic Spinal Cord Injury.

Life (Basel, Switzerland)·2023

Same author

Role of Subcutaneous Adipose Tissues in the Pathophysiology of Secondary Lymphedema.

Lymphatic research and biology·2022

Same author

Orchestration of Ion Channels and Transporters in Neocortical Development and Neurological Disorders.

Frontiers in neuroscience·2022

Same author

BMP10 expression in the adult rat central nervous system.

Journal of chemical neuroanatomy·2022

Search research articles

Related Experiment Video

Updated: Nov 21, 2025

Developing a Rat Model for Bipolar Disorder

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Why is lithium effective in alleviating bipolar disorder?

¹Department of Organ & Tissue Anatomy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashiku, Hamamatsu, Shizuoka 431-3192, Japan.

Medical Hypotheses

|January 14, 2021

Summary

Lithium stabilizes mood in bipolar disorder (BD) by regulating glycogen synthase kinase-3β (GSK3β) activity and potassium channels. This dual action normalizes neuronal excitability, reducing mood swing amplitude in both depressive and manic states.

Keywords:

Bipolar disorder GSK3β Lithium Mood swing

More Related Videos

The Tail Suspension Test

The Tail Suspension Test

Published on: January 28, 2012

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders

Published on: December 4, 2014

Related Experiment Videos

Last Updated: Nov 21, 2025

Developing a Rat Model for Bipolar Disorder

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

The Tail Suspension Test

The Tail Suspension Test

Published on: January 28, 2012

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders

Published on: December 4, 2014

Area of Science:

Neuroscience
Pharmacology
Biochemistry

Background:

Bipolar disorder (BD) is characterized by extreme mood swings between depression and mania.
Lithium is a primary treatment for BD, but its precise mechanism of action remains unclear.
Glycogen synthase kinase-3β (GSK3β) plays a role in neuronal excitability, influenced by neurotransmitters and signaling pathways.

Purpose of the Study:

To elucidate the mechanism by which lithium stabilizes mood in bipolar disorder.
To investigate the role of GSK3β and potassium channels in lithium's therapeutic effects.

Main Methods:

Analysis of GSK3β inhibition by lithium.
Examination of lithium's effect on K+ channel activation and neuronal excitability.
Correlation of GSK3β activity and K+ channel function with mood states.

Main Results:

Lithium's inhibition of GSK3β increases neuronal excitability, potentially alleviating depressive states.
Lithium's inhibition of K+ channel activation reduces neuronal excitability, potentially mitigating manic states.
Lithium dose-dependently reduces the amplitude of GSK3β activity swings, normalizing mood.

Conclusions:

Lithium normalizes mood swings in bipolar disorder through a dual mechanism.
Inhibition of GSK3β and K+ channels by lithium restores balanced neuronal excitability.
Understanding these pathways offers insights into novel therapeutic strategies for mood disorders.